SLIDE 2 NOTES: I was asked to answer, or try to answer, 5 questions related to compliance with colorectal cancer (CRC) screening. This presentation represents an update on reviews I have conducted with colleagues in the recent past (Peterson and Vernon, 2000; Vernon, 1997). The answers to some of the questions, such as the first two, are straightforward, and we have a reasonable amount of published data to draw on in answering those questions.
The 3rd question requires some extrapolation from existing data because it hasn’t been studied directly. I will share some thoughts about how we might arrive at a best guess, but I think this question warrants discussion.
There aren’t much published data to address the 4th question for any cancer screening test. But I will summarize the available data.
And to answer the 5th question, I plan to turn the podium over to my colleague Dr. Seeff, who has led a study by the CDC that may provide insight to help us answer this important question.
The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Appendix L Current Evidence on Compliance --Sally W. Vernon, M.A., Ph.D. ."
Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary . Washington, DC: The National Academies Press,
Please select a format: